LITSLite Strategy
Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. 10-K, Item 1
- Headquarters
- San Diego, CA
- CEO
- Justin J. File
- Next results
- around Feb 16, 2027
About Lite Strategy
10-K, Sep 28, 2026Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. During fiscal year 2026, we commenced pre-clinical development programs in nononcologic disease indications. We also hold Litecoin (LTC) tokens as a primary reserve asset as part of our broader institutional treasury initiative. We initially built our pipeline by acquiring promising cancer agents and creating value in programs through clinical development, strategic partnerships, and out-licensing or commercialization, as appropriate.
- Headquarters
- San Diego, CA
- Country
- United States
- Reports in
- USD
- Listed on
- Nasdaq
- Fiscal year ends
- June 30
- Last results
- Jul 30, 2026
- Incorporated in
- DE
Permanent link, kept if the ticker changes: /c/sec:0001262104 (SEC's CIK).
Work on LITS in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/LITS/export.csv") into a cell.